Publication
Biomarkers for the clinical management of breast cancer: international perspective.
Authors not recorded
Int J Cancer2013PMID 23280579stubpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CIVIC-20260908-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
No abstract stored. Read on PubMed
Linked entities
Linked entities (4)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 4
- cancerMalignant Breast Neoplasmcivic_curation1.00
- drugTamoxifencivic_curation1.00
- genePGRcivic_curation1.00
- variantPGR Expressioncivic_curation1.00
Curated evidence
Evidence citing this paper (1)
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 23280579
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| PGR Expression1 | ||||||||
| Tamoxifen | Malignant Breast Neoplasm | Predictive | B | Does Not Support Sensitivity Response | 1 | accepted | EID501In patients with ER-Positive breast cancer, expression of PgR does not effect the outcome of treatment with tamoxifen. PMID 23280579 · Patani et al., 2013 · Open in CIViC | civic |